Cerianna™ (fluoroestradiol F18) injection

At a glance
ico-plusminus-32

ER discordance in MBC

ico-ct-pet

Detecting ER+ lesions

ico-settings-32

Unique mechanism of action

ico-globalstack-32

Concordance with biopsy

Production site locations

Cerianna is available within a 3-hour radius from PETNET radiopharmacies

SEEING CLEARER

The only imaging agent that detects whole-body ER+ lesion status

Unique mechanism of action that detects ER+ lesions*†5
Verified concordance with biopsy for determining ER status in MBC* 1

Distinct mode of action that may help inform clinical decisions

F18 fluoroestradiol and FDG PET images in a MBC treatment responder and non-responder*†15

cerianna-patient-1-v2
Patient 1 (anterior/superior) responded to treatment with an AI and a CDK 4/6 inhibitor*15
cerianna-patient-2-v2
Patient 2 (anterior/superior) did not respond to treatment with an AI and a CDK 4/6 inhibitor*15

Potential clinical applications

ico-sync

Determine ER+ status in recurrent or metastatic lesions, as an adjunct to biopsy

ico-search-32

Assess ER+ status in difficult-to-biopsy lesions

ico-checkmark-32

Evaluate extent of ER expression in indolent tumors

ico-lightbulb-32

May resolve clinical dilemmas after inconclusive results from conventional assessment

Safety

Looking for medical information?

Interpreter Training

Have a question? We would love to hear from you.